E in PMC 2017 November 01.Luskin et al.Pagethat the GVL response
E in PMC 2017 November 01.Luskin et al.Pagethat the GVL response does not efficiently overcome treatment resistance. Experimental approaches to minimize relapse risk might be suitable for sufferers with TP53-mutated…